Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Merck Ord Shs MKGAF

Alternate Symbol(s): MKKGY

Healthcare

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical... see more

Add To Watchlist

Recent & Breaking News (OTCPK:MKGAF)

Merck Announces Recipients of Third Annual €1 Million 'Grant for Oncology Innovation' Award

PR Newswire Europe Non Regulatory October 10, 2016

Merck Launches Two Innovative Technologies to Support Couples on Their Fertility Treatment Journey

Canada NewsWire October 4, 2016

Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

PR Newswire Europe Non Regulatory September 28, 2016

Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

PR Newswire September 28, 2016

Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

PR Newswire September 28, 2016

Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016

PR Newswire Europe Non Regulatory September 28, 2016

Merck KGaA, Darmstadt, Germany and the Royal Health Awareness Society Partner to Advance Women's Health in Jordan

PR Newswire September 22, 2016

Merck and the Royal Health Awareness Society Partner to Advance Women's Health in Jordan

PR Newswire Europe Non Regulatory September 22, 2016

Merck Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis

PR Newswire Europe Non Regulatory September 16, 2016

Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators

Benzinga.com June 13, 2016

Merck Unites With UNESCO to Build Research Capacity in Africa

PR Newswire October 19, 2015

Juniper Pharmaceuticals Announces Regulatory Approvals for CRINONE® Progesterone Gel in Nine New EU Countries

PR Newswire July 28, 2015

Merck KGaA, Darmstadt, Germany: Innovative Fertility Technologies Gavi and Geri of Partner Genea Biomedx Receive CE Mark

PR Newswire June 14, 2015

Merck KGaA, Darmstadt, Germany, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment

PR Newswire June 8, 2015

Merck Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Children with PKU Below 4 Years of Age

PR Newswire May 22, 2015

Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer

PR Newswire May 12, 2015

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care'

PR Newswire September 26, 2014

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time

PR Newswire September 19, 2014

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

PR Newswire September 3, 2014

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

PR Newswire August 27, 2014